1074365-84-6 (4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯,4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-4-(2-oxo-1-piperidinyl)phenyl-1H-Pyrazolo3,4-cpyridine-3-carboxylic Acid Methyl Ester)

CAS号:
1074365-84-6
中文名称:
4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯
英文名称:
4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-4-(2-oxo-1-piperidinyl)phenyl-1H-Pyrazolo3,4-cpyridine-3-carboxylic Acid Methyl Ester
分子式:
C26H26N4O5
分子量:
474.508446216583
API:

4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯(1074365-84-6)名称与标识符

名称

中文别名:
4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯;阿哌沙班杂质6;阿哌沙班杂质D;1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-, m;
英文别名:
1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-, methyl ester;4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-Pyrazolo[3,4-c]pyridine-3-carboxylic Acid Methyl Ester;methyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate;Apixaban Impurity 6;Apixaban Acid Methyl Ester;BCP33002;1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid,4,5,6,7-tetrahydro-1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-,Met;Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridin;methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate;1-(4-Methoxy;Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,;4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-4-(2-oxo-1-piperidinyl)phenyl-1H-Pyrazolo3,4-cpyridine-3-carboxylic Acid Methyl Ester;methyl1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate;LN8E66QU6W;Apixaban Related Compound E;CS-M2736;Methyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-...;Apixaban Methyl Ester Impurity;F19508;SCHEMBL15883174;1074365-84-6;Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate;Apixaban Related Compound E [USP RS;1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-, methyl ester (ACI); Methyl 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyri;Apixaban Related Compound E [USP IMPURITY];IA184038;Methyl 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylate;

标识符

InChIKey:
IHFSYYKSFUFOTJ-UHFFFAOYSA-N
Inchi:
1S/C26H26N4O5/c1-34-20-12-10-19(11-13-20)30-24-21(23(27-30)26(33)35-2)14-16-29(25(24)32)18-8-6-17(7-9-18)28-15-4-3-5-22(28)31/h6-13H,3-5,14-16H2,1-2H3
SMILES:
O=C1C2=C(C(C(=O)OC)=NN2C2C=CC(=CC=2)OC)CCN1C1C=CC(=CC=1)N1C(CCCC1)=O

4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯(1074365-84-6)物化性质

实验特性

  • 沸点 : NA
  • 熔点 : NA

计算特性

  • 精确分子量 : 474.19032g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 6
  • 同位素质量 : 474.19032g/mol
  • 重原子数量 : 35
  • 复杂度 : 793
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.2
  • 拓扑分子极性表面积 : 94
  • 分子量 : 474.5g/mol

4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯(1074365-84-6)安全信息

4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯(1074365-84-6)推荐厂家 更多厂家(21)

4,5,6,7-四氢-1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代-1-哌啶基)苯基]-1H-吡唑并[3,4-c]吡啶-3-羧酸甲酯(1074365-84-6)参考资料

Reaxys RN:
PubChem CID: